Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07422571 · ClinicalTrials.gov registry record · NA
Body Acceptance After Baby Intervention
A NA study of Body Dissatisfaction, sponsored by Northeastern University.
- Recruiting
- Registry status
- NA
- Development phase
- 375
- Enrollment target
- 1
- Study location
NCT07422571: Recruiting NA study of Body Dissatisfaction, sponsored by Northeastern University.
NCT07422571 is a NA study of Body Dissatisfaction that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 375 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07422571, a NA study of Body Dissatisfaction, is actively recruiting participants, sponsored by Northeastern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn if a novel online single-session intervention can help improve body dissatisfaction in new moms. The active intervention condition, Body Acceptance After Baby (BABI), uses acceptance-based skills to help participants cope with body dissatisfaction. BABI will be evaluated against another active intervention condition (a brief infographic that provides psychoeducation about body image during postpartum) and a waitlist control condition.
Primary Outcome
Postpartum body image will be measured using the Body Image in Pregnancy Scale adapted for postpartum. Only the following subscales will be measured: (1) Preoccuptation with Physical Appearance; (2) Prioritization of Appearance over Function; (3) Appearance-Related Behavioral Avoidance. Subscales range from 1-5 with higher scores indicating greater body image disturbance.
Conditions Studied
Interventions
- BEHAVIORAL Body Acceptance after Baby (BABI)
- BEHAVIORAL Postpartum Body Image Infographic
Study Locations (1)
Massachusetts
- Northeastern University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07422571 shows while recruiting
NCT07422571 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Body Dissatisfaction appearing as the primary indexed condition, and to 2 interventions - of which Body Acceptance after Baby (BABI) is the first listed.
NCT07422571 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07422571 about?
NCT07422571 is a clinical study titled "Body Acceptance After Baby Intervention". The purpose of this study is to learn if a novel online single-session intervention can help improve body dissatisfaction in new moms. The active intervention condition, Body Acceptance After Baby (BABI), uses acceptance-based skills to help participants cope with body dissatisfaction. BABI will be ...
What is the current status of trial NCT07422571?
This trial is currently recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2026-01-20. Estimated completion is 2027-12.
What conditions does trial NCT07422571 study?
This clinical trial studies the following conditions: Body Dissatisfaction.
What interventions are being tested in trial NCT07422571?
The interventions under investigation include: Body Acceptance after Baby (BABI) (BEHAVIORAL), Postpartum Body Image Infographic (BEHAVIORAL).
Who is sponsoring clinical trial NCT07422571?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07422571 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Dissatisfaction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07422571's enrollment target sits among peer trials
375 276th of 2000 higher than 1,721 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI